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Abstract 
Molecular simulations are now commonly used to complement experiments in the investigation of amyloid 
formation and their role in human diseases. While various simulations based on enhanced sampling techniques are 
used in amyloid formation simulations, this article will focus on those using standard atomistic simulations to 
evaluate the stability of fibril models. Such studies explore the limitations that arise from the choice of force field or 
polymorphism; and explore the stability of in vivo and in vitro forms of A fibril aggregates, and the role of 
heterologous seeding as a link between different amyloid diseases.  
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Introduction  
 
Peptides in the amyloid state are (Figure 1) highly ordered structures stabilized by networks of hydrogen 
bonds between -strands within a single -sheet (intra-sheet) and cross--sheet packing (steric zipper-like 
interactions) of extended intermolecular -sheets into multi-sheet proto-filaments (inter-sheet) (Knowles et al., 
2014). Deposits of amyloids are associated with a growing number of human diseases, possibly caused by toxic 
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aggregates that are thought to be not the final fibril themselves but transient pre-fibril oligomer species. These 
oligomers are believed to damage cells by disruption of cell membranes and/or through dislocation of other proteins 
in the cell membrane (Knowles et al., 2014). Hence, characterization of the mechanisms by which amyloids form 
and become toxic may allow for design of small molecules which can disrupt these processes, potentially leading to 
new drug candidates (Baral et al., 2014). Molecular dynamics simulations starting from or guided by experiments 
are a way to extrapolate possible conformations of molecular systems and the different paths between them, thereby 
complementing experiments in probing protein folding, aggregation; and such predictions can guide further 
experiments (Shea and Urbanc, 2012).  
 
Figure 1 Amyloid structure. A) Structural model of amyloid fiber.  B) Side chain steric zipper interaction (magenta) 
of adjacent -sheets. C) Strong backbone interaction (backbone hydrogen bonds shown in red dots). 
 
A number of enhanced sampling methods have been reported for atomistic simulations of the early stages 
of aggregation, and have been reviewed previously (Straub and Thirumalai, 2010), (Straub and Thirumalai, 2011). 
These methods enhance sampling of conformations but cannot provide a realistic path of folding and aggregation 
(Berhanu and Hansmann, 2014a). Coarse-grained simulations have been utilized to gain insight into the crucial 
intermediate steps between small oligomers and mature fibrils, and were recently reviewed by the Shea group 
(Morriss-Andrews and Shea, 2014). This article focuses on computational stability studies of given fibril structures 
(derived from experimental data). They are based on the notion that when during a sufficiently long simulation 
model aggregates do not dissociate, they can be considered stable (Berhanu and Hansmann, 2014a), (Berhanu and 
Hansmann, 2012b). Even though amyloid assembly is not probed directly in such studies, indirectly factors can be 
identified which add to or moderate fibril formation (Berhanu and Hansmann, 2014a). We will show that such 
simulations can both explain and guide experimental findings (Shea and Urbanc, 2012). In the following, we will 
describe some of our recent findings.  
 
2.  Force field choice for simulation of preformed oligomer 
 
The choice of force field is critical in a molecular dynamics including that for the formed amyloid fibrils 
(Berhanu and Hansmann, 2012a). A comparative simulation of A16–22 aggregates using frequently used force 
fields, showed that two recent versions of AMBER force fields have consistently smaller root mean square 
deviations to the initial configuration (Berhanu and Hansmann, 2012a). While the force field-induced bias becomes 
smaller as the size of the aggregates increases, suggesting that the selection of a force field becomes less of a 
problem with increasing size of the system, there is a need for carefully choosing an acceptable force field in 
simulations of amyloids. This has been also recognized in other simulations. For instance, Nguyen et al (Nguyen et 
al., 2011) noted the force field dependence of oligomer formation of A. 
 
3. Amyloid polymorphism  
 
 Understanding oligomer formation is critical for rational design of therapeutics; however, usually there is 
not a single structure for such aggregates but polymorphism controlled by the physicochemical environment. This 
polymorphism could be fibril variability through simple side-chain rotations or segmental polymorphism (Wiltzius 
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et al., 2009). It has been proposed (Wiltzius et al., 2009) that structural polymorphism of amyloids tunes the 
functional or toxic properties of aggregates. Skeby et al (Skeby et al., 2013) have investigated the interaction of 
amyloid imaging agents with a fibril model using molecular dynamics simulations. While these amyloid imaging 
agents can bind in surface grooves, the particular binding position and affinity of a ligand for an amyloid fibril 
depends on ligand differences as well as the fibril morphology. Therefore, in order to understand fibril self-assembly 
and for the rational design of imaging agents, one has to take into account the polymorphic nature of the aggregates. 
For instance, polymorphism in A fibrils leads to differences in the degree of toxicity (Petkova et al., 2005).  
A problem with testing the above questions is the lack of suitable model systems. The Eisenberg group has 
proposed a -barrel oligomer conformation (Laganowsky et al., 2012) as test system for computational studies of 
oligomer formation. In order to ascertain the factors which control the stability of -barrel amyloid oligomers, we 
have explored the stability of the cylindrin -barrel tandem repeat, single-chain cylindrin, and the steric zipper fibril 
(Berhanu and Hansmann, 2013). We observe in our simulations water molecules within the -barrel, which suggests 
leakage of water and ions through these oligomers (inserted in cell membranes) as a potential toxicity mechanism. 
The free energy difference between the fibril models and -barrel cylindrin models indicate that the fibril models are 
more stable than the -barrel.  
In other research, Colletier et al. (Colletier et al., 2011) have built various polymorphic models of A, 
which involves different segmental packing of -sheets. The interactions at the -sheet–-sheet interface of these 
models differ in length and nature of participating side chains. We have examined the stability of such models using 
molecular dynamics simulations (Berhanu and Hansmann, 2012b) and found that the stability depends on the length 
of the -sheet–-sheet interface and the nature of amino acid side chains involved. However, we see full retention of 
the original U-shaped form in all our models, consistent with in vitro experimental observations (Petkova et al., 
2005). 
An important question is the conversion between various polymorphs. Take as an example a Amyloid-beta 
(A) aggregates which are a hallmark of Alzheimer’s disease. Rare familial forms have been identified that involve 
a single amino acid mutations and that lead to early onset and increased severity of the disease. An example is the 
Iowa mutant, which has the single amino acid mutation (D23N). While wild-type Amyloid -peptides aggregates 
seem to form only parallel beta-sheet, the Iowa mutant forms a mixtures of parallel and antiparallel  sheet fibril 
structures, with the antiparallel beta sheets being meta-stable under physiological buffer conditions (Qiang et al., 
2012). We designed in silico studies to probe the relative stability of the parallel and antiparallel forms of wild type 
and Iowa mutant (Alred et al., 2014). Through the comparison of the all-atom molecular dynamics simulations, we 
can probe the various interactions that stabilize the structural differences and potentially lead to the different 
pathologies (Figure 2). 
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Figure 2: A-D shows the protein-protein hydrogen bonding of the mutated 23rd residue (red for D23 wild type and 
blue for N23 Iowa mutant) for a 10 strand 2 layer system of: A) antiparallel wild type, B) parallel wild type, C) 
antiparallel Iowa mutant, D) parallel Iowa mutant. E-H shows the protein solvent hydrogen bonding of E) 
antiparallel wild type, F) parallel wild type, G) antiparallel Iowa mutant, H) parallel Iowa mutant. These show a 
clear trend that the N23 Iowa mutant has more stabilizing protein-protein hydrogen bonds, which appear strongest in 
the antiparallel system. 
 
 Visual inspection indicates stability of parallel aggregates of both peptides, while the aggregates become 
meta-stable in the antiparallel Iowa mutant, and are further destabilized for the wild type. Comparison of the free 
energy of binding, approximated by the MM-PBSA method, supports this observation that the most stable 
aggregates are the parallel forms of both peptide sequences, while the antiparallel systems are less stable, with the 
Iowa mutant being more stable than wild type. This difference is due to the direct alignment of hydrophobic residues 
in the in-register parallel oligomers that can overcome potential repulsive interactions of aligned charged residues 
seen in antiparallel aggregates, making it energetically more favorable. The minor increase in the thermodynamic 
stability of the Iowa mutant oligomer in its parallel organization over that of the antiparallel form is in line with 
previous experimental measurements (Qiang et al., 2012) showing a gradual inter-conversion of antiparallel to 
parallel aggregates. Our calculations indicate the existence of both parallel and anti-parallel -sheet fibrils under 
physiological conditions; even through there are large differences in thermodynamic and structural stability. Hence, 
both forms will likely contribute to the polymorphism observed in A aggregates (Alred et al., 2014). Our data 
suggest that one has to use both the parallel and anti-parallel -sheet fibrils as templates for A aggregation inhibitor 
design. 
 
4 In vivo and in vitro Amyloid Aggregates stability 
 
The above described polymorphism has been well described for in vitro aggregates of A peptides. 
However, in vivo A fibrils obtained from the brains of Alzheimer’s patients do not show polymorphism (Lu et al., 
2013). This has motivated us to compare the structural stability of the various solid state NMR-derived in vivo and 
in vitro A fibril models. In order to investigate the factors that control the stability of A-fibrils, we used molecular 
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dynamic simulations with enhanced sampling. We observe variation in dynamics of interactions, structural behavior 
and molecular flexibility that are characteristic for the in vitro A-fibril structure and brain derived models. Our 
results indicate that the difference in stability is due to the different in frequencies of hydrophobic contacts between 
inter-strand loop-strand sub units: the two-fold system is more stable due to a longer association of the -sheets of 
the two adjacent strand-loop-strand units through tight side chain complementarity. These differences in stability 
become smaller as the size of the aggregates increases  (Figure 3).  
 
 
 
Figure 3: Shows the structure of systems of in vitro (blue) and in vivo (red) models after 100 ns of simulation, and 
the associated RMSD. These structures are A) 6 layer in vitro B) 6 layer in vivo C) 12 layer in vitro D) 12 layer in 
vivo. As shown, the structural changes are more noticeable in the 6 layer system with a higher RMSD from the 
initial structure.  
All systems maintained their original morphology in the largest measured aggregates; however, the in vivo 
model has lower stability than both forms of in vitro models (two-fold symmetry and three-fold symmetry) 
suggesting that brain-derived structures are not easily attainable using in vitro conditions, i.e. in solution. As the 
brain-derived aggregates strongly resemble fibril structures of A formed in the presence of the lipid vesicles, it 
seems likely that the lack of polymorphism in the brain derive fibrils is due to the different environmental condition 
by which the in vitro and in vivo fibrils grow (Erik J. Alred et al., 2015). We remark that we observe presence of 
water molecules in the central columns of models with three-fold symmetry (both in vivo and in vitro). This 
observation adds evidence to the hypothesis of water leakage as the mechanism of toxicity for amyloids (Erik J. 
Alred et al., 2015).  
 
5. Cross Seeding of amyloids 
 
The amyloids formation involves three steps: a lag, a growth, and an equilibration phase (Harper and 
Lansbury, 1997). Seeding accelerates the lag phase. Seeding involves the addition of existing fibrils to a solution of 
monomers (Morales et al., 2013). The seeds can be either homogenous (same peptide) or heterogeneous (related or 
unrelated peptides) as illustrated in Figure 4. Recent studies of amyloid growth indicate that both pathogenic self-
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association and cross-seeding can contribute to amyloid diseases. Especially, cross-seeding may explain the 
coexistence of diseases observed in patients afflicted by more than one protein mis-folding disorder. Oskarsson et al 
(Marie E. Oskarsson et al., 2015) found that the molecular interaction between amyloid forms of amylin and  
amyloid-beta (A) peptides induces amyloid formation in the pancreas of amylin-humanized mice. Such 
heterologous seeding between amylin and A may represent a molecular link between Type-2 diabetes and 
Alzheimer’s disease (Jackson K et al., 2013). For this reason, we have numerically investigated the stability and 
conformational changes of mixed A-amylin oligomers (Berhanu et al., 2013). Our results on the stability of these 
mixed aggregates, and the presence of a water channel, suggests again water-leakage as cytotoxic mechanism in the 
pathogenesis of the two diseases, and are in agreement with experimental data (Jackson K et al., 2013), (Marie E. 
Oskarsson et al., 2015). 
 
 
 
Figure 4 Illustration of amyloid formation and cross seeding. A) The lag time is shortened in the presence of seeding 
(I versus II). B) The seeding could occur between identical (homologous seeding) or different (heterologous 
seeding) peptides. 
 
We have also probed how mutations alter the seeding of amylin fibrils and how seeding dependence on 
structure similarity. Our studies on aggregates build out of mixtures of wild-type and mutant amylin explain the 
experimentally observed cross seeding with the similar side chains packing at the -sheet interface that can serves as 
template. However, we find also that the lack of tyrosine-specific interactions in Y37L mutants causes significant 
larger flexibility of the C terminal therefore hindering elongation of the Y37L mutant fibril and leading to longer lag 
times (Bernhardt et al., 2013). The related atomic level simulation (Berhanu and Hansmann, 2014b) on the 
interaction of rat amylin and human amylin aggregates explain the experimentally observed  (Young et al., 2014) 
aggregation  of rat amylin which was thought to be inhibiting aggregation (Berhanu and Hansmann, 2014b). 
 
7. Conclusions and Outlook 
We have shown in this review how molecular dynamics simulations starting from existing structures of 
aggregates can be used to compliment experiments in studies of amyloids and their role in human diseases. We have 
shown that while these simulations require a careful selection of both the underlying protein models and energy 
functions, the degree of accuracy provided by the present generation of force fields is sufficient to offer meaningful 
and quantitative predictions that can guide further experiments. For this reason, we expect that despite the well-
known sampling difficulties the role of computational studies in aggregation even more increase in the next years.  
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